Compounds > epigallocatechin gallate
Page last updated: 2024-08-24

epigallocatechin gallate and ER-Negative PR-Negative HER2-Negative Breast Cancer

epigallocatechin gallate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (41.67)24.3611
2020's7 (58.33)2.80

Authors

AuthorsStudies
Ham, J; Hwang, GS; Jang, HJ; Kang, KS; Kim, HY; Kim, KH; Kwak, JH; Kwak, JY; Lee, D; Park, EH; Park, HJ; Park, JY; Yamabe, N1
Annabi, B; Fernandez-Marrero, Y; Gonzalez Suarez, N; Torabidastgerdooei, S1
Chang, HW; Chen, LC; Cheng, TC; Fang, CL; Ho, YS; Kuo, CC; Lee, WJ; Liao, YC; Lin, LC; Tu, SH; Yen, Y1
Jordan, HR; Steed, KL; Tollefsbol, TO1
Assumpção, JHM; Rainho, CA; Sforcin, JM; Takeda, AAS1
Banerjee, S; Banerjee, SK; Chatterjee, I; Das, A; De, A; Dutta, D; Ghosh, A; Gunewardena, S; Haque, I; Quadir, M; Ray, P; Weir, S1
Annabi, B; El Cheikh-Hussein, L; Gonzalez Suarez, N; Ouanouki, A; Rodriguez Torres, S1
Kollareddy, M; Martinez, LA1
Camó, C; Crous-Masó, J; Feliu, L; Martínez-Garza, Ú; Palomeras, S; Planas, M; Puig, T; Relat, J1
Ciurana, J; Feliu, L; Giró-Perafita, A; Planas, M; Puig, T; Rabionet, M; Ruiz-Martínez, S1
Achimas-Cadariu, P; Berindan-Neagoe, I; Braicu, C; Chira, S; Petric, RC; Pileczki, V; Pointiere, E; Pop, L1
Foygel, K; Paulmurugan, R; Sekar, TV1

Other Studies

12 other study(ies) available for epigallocatechin gallate and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells.
    Bioorganic & medicinal chemistry letters, 2014, Dec-01, Volume: 24, Issue:23

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Female; Humans; Panax; Sapogenins; Triple Negative Breast Neoplasms

2014
EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome.
    Nutrients, 2022, Mar-05, Volume: 14, Issue:5

    Topics: Adipocytes; Catechin; Humans; Mesenchymal Stem Cells; Phenotype; Secretome; Triple Negative Breast Neoplasms; Tumor Microenvironment

2022
Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects.
    Journal of food and drug analysis, 2021, 03-15, Volume: 29, Issue:1

    Topics: Animals; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Mice; Polyphenols; Proline; Proline Oxidase; Tea; Triple Negative Breast Neoplasms

2021
SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2.
    Anticancer research, 2020, Volume: 40, Issue:1

    Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Caspase 7; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Triple Negative Breast Neoplasms; Vorinostat

2020
Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms.
    Molecules (Basel, Switzerland), 2020, Mar-12, Volume: 25, Issue:6

    Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxybenzoates; Molecular Docking Simulation; Propolis; Triple Negative Breast Neoplasms

2020
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:2

    Topics: Animals; Apoptosis; Catechin; CCN Intercellular Signaling Proteins; Cell Line, Tumor; Cell Survival; Female; Humans; Mice; Nanoparticle Drug Delivery System; Repressor Proteins; Spheroids, Cellular; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2021
EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype.
    Molecules (Basel, Switzerland), 2021, Mar-10, Volume: 26, Issue:6

    Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Culture Media, Conditioned; Female; Humans; Leptin; Mesenchymal Stem Cells; Mice; Paracrine Communication; STAT3 Transcription Factor; Tea; Triple Negative Breast Neoplasms

2021
Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line.
    Cells, 2021, 04-02, Volume: 10, Issue:4

    Topics: Biological Products; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Flavonoids; Humans; Mutant Proteins; Mutation; Neoplasm Invasiveness; Oncogenes; Polyphenols; Proto-Oncogene Proteins c-ets; RNA, Messenger; Transcription, Genetic; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2021
(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer.
    Molecules (Basel, Switzerland), 2018, May-11, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Fatty Acid Synthases; Female; Humans; Molecular Structure; Triple Negative Breast Neoplasms

2018
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models.
    Molecules (Basel, Switzerland), 2019, Mar-15, Volume: 24, Issue:6

    Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Structure; Neoplastic Stem Cells; Paclitaxel; Triple Negative Breast Neoplasms

2019
Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Anticarcinogenic Agents; Apoptosis; Autophagy; Blotting, Western; Catechin; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2015
Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Animals; Antioxidants; Apoptosis; Blotting, Western; Catechin; Cell Proliferation; Cells, Cultured; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Mice; Mice, Nude; NF-E2-Related Factor 2; Oxidative Stress; Response Elements; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2015